291 related articles for article (PubMed ID: 37245517)
1. The third Intensive Care Bundle with Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT3): an international, stepped wedge cluster randomised controlled trial.
Ma L; Hu X; Song L; Chen X; Ouyang M; Billot L; Li Q; Malavera A; Li X; Muñoz-Venturelli P; de Silva A; Thang NH; Wahab KW; Pandian JD; Wasay M; Pontes-Neto OM; Abanto C; Arauz A; Shi H; Tang G; Zhu S; She X; Liu L; Sakamoto Y; You S; Han Q; Crutzen B; Cheung E; Li Y; Wang X; Chen C; Liu F; Zhao Y; Li H; Liu Y; Jiang Y; Chen L; Wu B; Liu M; Xu J; You C; Anderson CS;
Lancet; 2023 Jul; 402(10395):27-40. PubMed ID: 37245517
[TBL] [Abstract][Full Text] [Related]
2. INTEnsive care bundle with blood pressure reduction in acute cerebral hemorrhage trial (INTERACT3): study protocol for a pragmatic stepped-wedge cluster-randomized controlled trial.
Song L; Hu X; Ma L; Chen X; Ouyang M; Billot L; Li Q; Muñoz-Venturelli P; Abanto C; Pontes-Neto OM; Antonio A; Wasay M; Silva A; Thang NH; Pandian JD; Wahab KW; You C; Anderson CS;
Trials; 2021 Dec; 22(1):943. PubMed ID: 34930428
[TBL] [Abstract][Full Text] [Related]
3. Statistical Analysis Plan for the INTEnsive Care Bundle with Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial: A Stepped-Wedge Cluster Randomized Controlled Trial.
Billot L; Song L; Hu X; Ma L; Ouyang M; Chen X; You C; Anderson CS;
Cerebrovasc Dis; 2023; 52(3):251-254. PubMed ID: 36063792
[TBL] [Abstract][Full Text] [Related]
4. Implementing a Goal-Directed Care Bundle after Acute Intracerebral Haemorrhage: Process Evaluation for the Third INTEnsive Care Bundle with Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial Study in China.
Ouyang M; Anderson CS; Song L; Jan S; Sun L; Cheng G; Chu H; Hu X; Ma L; Chen X; You C; Liu H
Cerebrovasc Dis; 2022; 51(3):373-383. PubMed ID: 34929690
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial.
Anderson CS; Huang Y; Lindley RI; Chen X; Arima H; Chen G; Li Q; Billot L; Delcourt C; Bath PM; Broderick JP; Demchuk AM; Donnan GA; Durham AC; Lavados PM; Lee TH; Levi C; Martins SO; Olavarria VV; Pandian JD; Parsons MW; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Silva F; Song L; Thang NH; Wardlaw JM; Wang JG; Wang X; Woodward M; Chalmers J; Robinson TG;
Lancet; 2019 Mar; 393(10174):877-888. PubMed ID: 30739745
[TBL] [Abstract][Full Text] [Related]
7. Intensive blood pressure control after endovascular thrombectomy for acute ischaemic stroke (ENCHANTED2/MT): a multicentre, open-label, blinded-endpoint, randomised controlled trial.
Yang P; Song L; Zhang Y; Zhang X; Chen X; Li Y; Sun L; Wan Y; Billot L; Li Q; Ren X; Shen H; Zhang L; Li Z; Xing P; Zhang Y; Zhang P; Hua W; Shen F; Zhou Y; Tian B; Chen W; Han H; Zhang L; Xu C; Li T; Peng Y; Yue X; Chen S; Wen C; Wan S; Yin C; Wei M; Shu H; Nan G; Liu S; Liu W; Cai Y; Sui Y; Chen M; Zhou Y; Zuo Q; Dai D; Zhao R; Li Q; Huang Q; Xu Y; Deng B; Wu T; Lu J; Wang X; Parsons MW; Butcher K; Campbell B; Robinson TG; Goyal M; Dippel D; Roos Y; Majoie C; Wang L; Wang Y; Liu J; Anderson CS;
Lancet; 2022 Nov; 400(10363):1585-1596. PubMed ID: 36341753
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial.
Hanley DF; Thompson RE; Rosenblum M; Yenokyan G; Lane K; McBee N; Mayo SW; Bistran-Hall AJ; Gandhi D; Mould WA; Ullman N; Ali H; Carhuapoma JR; Kase CS; Lees KR; Dawson J; Wilson A; Betz JF; Sugar EA; Hao Y; Avadhani R; Caron JL; Harrigan MR; Carlson AP; Bulters D; LeDoux D; Huang J; Cobb C; Gupta G; Kitagawa R; Chicoine MR; Patel H; Dodd R; Camarata PJ; Wolfe S; Stadnik A; Money PL; Mitchell P; Sarabia R; Harnof S; Barzo P; Unterberg A; Teitelbaum JS; Wang W; Anderson CS; Mendelow AD; Gregson B; Janis S; Vespa P; Ziai W; Zuccarello M; Awad IA;
Lancet; 2019 Mar; 393(10175):1021-1032. PubMed ID: 30739747
[TBL] [Abstract][Full Text] [Related]
9. Prehospital transdermal glyceryl trinitrate in patients with presumed acute stroke (MR ASAP): an ambulance-based, multicentre, randomised, open-label, blinded endpoint, phase 3 trial.
van den Berg SA; Uniken Venema SM; Reinink H; Hofmeijer J; Schonewille WJ; Miedema I; Fransen PSS; O Pruissen DM; Raaijmakers TWM; van Dijk GW; de Leeuw FE; van Vliet JA; Kwa VIH; Kerkhoff H; van 't Net A; Boomars R; Siegers A; Lok T; Caminada K; Esteve Cuevas LM; Visser MC; Zwetsloot CP; Boomsma JMF; Schipper MH; van Eijkelenburg RPJ; Berkhemer OA; Nieboer D; Lingsma HF; Emmer BJ; van Oostenbrugge RJ; van der Lugt A; Roos YBWEM; Majoie CBLM; Dippel DWJ; Nederkoorn PJ; van der Worp HB;
Lancet Neurol; 2022 Nov; 21(11):971-981. PubMed ID: 36058230
[TBL] [Abstract][Full Text] [Related]
10. Blood pressure control and clinical outcomes in acute intracerebral haemorrhage: a preplanned pooled analysis of individual participant data.
Moullaali TJ; Wang X; Martin RH; Shipes VB; Robinson TG; Chalmers J; Suarez JI; Qureshi AI; Palesch YY; Anderson CS
Lancet Neurol; 2019 Sep; 18(9):857-864. PubMed ID: 31397290
[TBL] [Abstract][Full Text] [Related]
11. Tranexamic acid versus placebo in individuals with intracerebral haemorrhage treated within 2 h of symptom onset (STOP-MSU): an international, double-blind, randomised, phase 2 trial.
Yassi N; Zhao H; Churilov L; Wu TY; Ma H; Nguyen HT; Cheung A; Meretoja A; Mai DT; Kleinig T; Jeng JS; Choi PMC; Duc PD; Brown H; Ranta A; Spratt N; Cloud GC; Wang HK; Grimley R; Mahawish K; Cho DY; Shah D; Nguyen TMP; Sharma G; Yogendrakumar V; Yan B; Harrison EL; Devlin M; Cordato D; Martinez-Majander N; Strbian D; Thijs V; Sanders LM; Anderson D; Parsons MW; Campbell BCV; Donnan GA; Davis SM;
Lancet Neurol; 2024 Jun; 23(6):577-587. PubMed ID: 38648814
[TBL] [Abstract][Full Text] [Related]
12. Tranexamic acid to improve functional status in adults with spontaneous intracerebral haemorrhage: the TICH-2 RCT.
Sprigg N; Flaherty K; Appleton JP; Al-Shahi Salman R; Bereczki D; Beridze M; Ciccone A; Collins R; Dineen RA; Duley L; Egea-Guerrero JJ; England TJ; Karlinski M; Krishnan K; Laska AC; Law ZK; Ovesen C; Ozturk S; Pocock SJ; Roberts I; Robinson TG; Roffe C; Peters N; Scutt P; Thanabalan J; Werring D; Whynes D; Woodhouse L; Bath PM
Health Technol Assess; 2019 Jul; 23(35):1-48. PubMed ID: 31322116
[TBL] [Abstract][Full Text] [Related]
13. The main Optimal Post rTpa-Iv Monitoring in Ischemic Stroke Trial (OPTIMISTmain): protocol for a pragmatic, stepped wedge, cluster randomized controlled trial.
Ouyang M; Faigle R; Wang X; Johnson B; Summers D; Khatri P; Billot L; Liu H; Malavera A; Munoz-Venturelli P; Gonzalez F; Urrutia F; Day D; Song L; Sui Y; Delcourt C; Robinson T; Durham AC; Ebraimo A; Wan Zaidi WA; Jan S; Lindley RI; Urrutia VC; Anderson CS
Cerebrovasc Dis; 2023 Oct; ():. PubMed ID: 37883934
[TBL] [Abstract][Full Text] [Related]
14. Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial.
Baharoglu MI; Cordonnier C; Al-Shahi Salman R; de Gans K; Koopman MM; Brand A; Majoie CB; Beenen LF; Marquering HA; Vermeulen M; Nederkoorn PJ; de Haan RJ; Roos YB;
Lancet; 2016 Jun; 387(10038):2605-2613. PubMed ID: 27178479
[TBL] [Abstract][Full Text] [Related]
15. Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial.
Selim M; Foster LD; Moy CS; Xi G; Hill MD; Morgenstern LB; Greenberg SM; James ML; Singh V; Clark WM; Norton C; Palesch YY; Yeatts SD;
Lancet Neurol; 2019 May; 18(5):428-438. PubMed ID: 30898550
[TBL] [Abstract][Full Text] [Related]
16. Apixaban versus no anticoagulation after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation in the Netherlands (APACHE-AF): a randomised, open-label, phase 2 trial.
Schreuder FHBM; van Nieuwenhuizen KM; Hofmeijer J; Vermeer SE; Kerkhoff H; Zock E; Luijckx GJ; Messchendorp GP; van Tuijl J; Bienfait HP; Booij SJ; van den Wijngaard IR; Remmers MJM; Schreuder AHCML; Dippel DW; Staals J; Brouwers PJAM; Wermer MJH; Coutinho JM; Kwa VIH; van Gelder IC; Schutgens REG; Zweedijk B; Algra A; van Dalen JW; Jaap Kappelle L; Rinkel GJE; van der Worp HB; Klijn CJM;
Lancet Neurol; 2021 Nov; 20(11):907-916. PubMed ID: 34687635
[TBL] [Abstract][Full Text] [Related]
17. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial.
Anderson CS; Huang Y; Wang JG; Arima H; Neal B; Peng B; Heeley E; Skulina C; Parsons MW; Kim JS; Tao QL; Li YC; Jiang JD; Tai LW; Zhang JL; Xu E; Cheng Y; Heritier S; Morgenstern LB; Chalmers J;
Lancet Neurol; 2008 May; 7(5):391-9. PubMed ID: 18396107
[TBL] [Abstract][Full Text] [Related]
18. Blood pressure variability and outcome after acute intracerebral haemorrhage: a post-hoc analysis of INTERACT2, a randomised controlled trial.
Manning L; Hirakawa Y; Arima H; Wang X; Chalmers J; Wang J; Lindley R; Heeley E; Delcourt C; Neal B; Lavados P; Davis SM; Tzourio C; Huang Y; Stapf C; Woodward M; Rothwell PM; Robinson TG; Anderson CS;
Lancet Neurol; 2014 Apr; 13(4):364-73. PubMed ID: 24530176
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of intensive blood pressure lowering after successful endovascular therapy in acute ischaemic stroke (BP-TARGET): a multicentre, open-label, randomised controlled trial.
Mazighi M; Richard S; Lapergue B; Sibon I; Gory B; Berge J; Consoli A; Labreuche J; Olivot JM; Broderick J; Duhamel A; Touze E; Qureshi AI; Yavchitz A; Escalard S; Desilles JP; Redjem H; Smajda S; Fahed R; Hébert S; Maïer B; Delvoye F; Boursin P; Maacha MB; Obadia M; Sabben C; Blanc R; Savatovsky J; Piotin M;
Lancet Neurol; 2021 Apr; 20(4):265-274. PubMed ID: 33647246
[TBL] [Abstract][Full Text] [Related]
20. Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial.
Sprigg N; Flaherty K; Appleton JP; Al-Shahi Salman R; Bereczki D; Beridze M; Christensen H; Ciccone A; Collins R; Czlonkowska A; Dineen RA; Duley L; Egea-Guerrero JJ; England TJ; Krishnan K; Laska AC; Law ZK; Ozturk S; Pocock SJ; Roberts I; Robinson TG; Roffe C; Seiffge D; Scutt P; Thanabalan J; Werring D; Whynes D; Bath PM;
Lancet; 2018 May; 391(10135):2107-2115. PubMed ID: 29778325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
